CFTR and cystic fibrosis: Westholter D. et al. conducted a longitudinal cohort study with peripheral blood mononuclear cells and serum samples collected from 108 patients with CF in order to evaluate if CFTR modulator therapy also targets T cells and thereby influences immune cell abnormalities in CF.